Published: 21/12/2009 17:38:45 - PDF Version (89 KB)
Researchers have developed a quick and efficient approach to nuclear reprogramming in order to understand the mechanisms leading to induced Pluripotent Stem (iPS) cells. Using this assay, they have identified a protein that is crucial for the reprogramming process. The work is published online this week in Nature.
Inducing pluripotency yields promise for patient-specific stem cells in regenerative medicine, but current methods are slow and inefficient. Helen Blau and colleagues fused mouse embryonic stem cells and human fibroblasts to induce reprogramming in just one day and with hugely improved efficiency. They show that Activation-induced cytidine deaminase (AID) — a protein known for its role in generating antibody diversity — is required for initiation of nuclear reprogramming towards pluripotency in human somatic cells. They believe the AID protein modifies the DNA directly by removing certain chemical groups, and that this activity enables reprogramming. Future studies will reveal whether the expression of AID alone can speed up iPS cell generation.
Article DOI:10.1038/nature08752
No comments have been posted yet. Post a comment.

Intensive chemotherapy may be harmful to most older patients with AML
New molecular marker could predict if breast cancer patients need chemotherapy
CTC screening for colorectal cancer not cost-effective when reimbursed at same rate as colonoscopy
Women in their forties have lower mammographic tumour detectability
Genetic risk score associated with breast cancer risk
New roundtable debate: communicating risk in familial cancer
Study finds that the GRB7 gene drives an aggressive form of the disease
ASCO updates guideline on adjuvant hormonal therapy for breast cancer
NICE guideline set to improve care of cancer patients with unknown primary